{"title":"Semaphorin-3A and urothelial carcinoma","authors":"Z. Vadas, J. Rubinstein, Z. Bahouth, S. Halachmi","doi":"10.31083/j.jmcm.2019.04.5061","DOIUrl":null,"url":null,"abstract":"therapy. Herein we review the current knowledge about Semaphorin-3A in UC.","PeriodicalId":92248,"journal":{"name":"Journal of molecular medicine and clinical applications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of molecular medicine and clinical applications","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31083/j.jmcm.2019.04.5061","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
therapy. Herein we review the current knowledge about Semaphorin-3A in UC.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
